No Data
No Data
No Data
No Data
No Data
Ortho Regenerative Technologies Inc. (OTCMKTS:ORTIF) Short Interest Update
Ortho Regenerative Technologies Inc. (OTCMKTS:ORTIF – Get Rating) saw a large drop in short interest in August. As of August 31st, there was short interest totalling 100 shares, a drop of 93.3% from
kopsourceSep 14, 2022 12:52 ET
CSE Bulletin: Name and Symbol Change - Ortho Regenerative Technologies Inc. (ORTH)
Toronto, Ontario--(Newsfile Corp. - Le 7 septembre/September 2022) - Ortho Regenerative Technologies Inc. (ORTH) has announced a name and symbol change to ChitogenX Inc. (CHGX) Shares will begin tradi
newsfileSep 7, 2022 12:20 ET
Ortho Regenerative Technologies Announces Name Change to ChitogenX Inc.
Ortho Regenerative Technologies (OTCQB:ORTIF) has changed its corporate name to ChitogenX Inc. The new name to better represent company's proprietary technology platform expanded applications beyond
Seeking AlphaSep 7, 2022 07:26 ET
Ortho Regenerative Technologies Inc. (OTCMKTS:ORTIF) Sees Significant Increase in Short Interest
Ortho Regenerative Technologies Inc. (OTCMKTS:ORTIF – Get Rating) was the recipient of a large increase in short interest in the month of August. As of August 15th, there was short interest totalling
kopsourceAug 27, 2022 22:41 ET
Ortho Regenerative Technologies GAAP EPS of -C$0.02
Ortho Regenerative Technologies press release (OTCQB:ORTIF): Q1 GAAP EPS of -C$0.02. Cash balance as April 30, 2022 of C$2.19M
Seeking AlphaJun 24, 2022 07:18 ET
ORTHO REGENERATIVE TECHNOLOGIES INITIATES PATIENTS RECRUITMENT FOR ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL
Contracting procedures completed for 6 of the 10 clinical trial sites 5 sites fully activated, with ongoing patients' screening and recruitment MONTREAL, June 13, 2022 /PRNewswire/ - Ortho Regenerative Technologies Inc. (CSE:ORTH) (OTCQB:ORTIF) ("O
PR NewswireJun 13, 2022 08:46 ET
No Data
No Data